| Business Type | Exporter, Supplier |
| Generic Name | Nivolumab |
| Usage | Treatment Of Various Cancers As Prescribed By An Oncologist |
| Form | Injectable Solution |
| Click to view more | |
Product Details
Opdivo® is a prescription immunotherapy (immune checkpoint inhibitor) used in oncology for the treatment of multiple types of cancer. It contains nivolumab, a monoclonal antibody that helps the immune system recognize and attack cancer cells. Opdivo is administered intravenously under specialist medical supervision.
Therapeutic Use / Application
Opdivo is indicated for the treatment of various cancers, including:
Melanoma
Non-small cell lung cancer (NSCLC)
Renal cell carcinoma
Hodgkin lymphoma
Head and neck squamous cell carcinoma
Urothelial carcinoma
Colorectal cancer (MSI-H or dMMR)
Esophageal and gastric cancers
Email: peptidevera@
Hi! Simply click below and type your query.
Our experts will reply you very soon.